Latest News & Updates
Breaking News
7 hours ago
Vaibhavi M.
Other trending news you may like to read
FDA Grants Full Approval To AbbVie’s EPKINLY + R2 For Relapsed Or Refractory Follicular Lymphoma
FDA approves EPKINLY + R2 for relapsed or refractory follicular lymphoma, offering stronger responses and a new chemotherapy-free treatment option.
Vaibhavi M.
Thermo Fisher Expands U.S. Cell And Gene Therapy Network With New Philadelphia ATxCC
Thermo Fisher opens its Philadelphia ATxCC, expanding support for cell and gene therapy development with advanced labs and collaboration resources.
Vaibhavi M.
Roche’s Giredestrant Achieves Strong Phase III Results In lidERA Early Breast Cancer Trial
Roche’s Phase III lidERA trial shows giredestrant significantly improves invasive disease-free survival in early-stage ER+, HER2– breast cancer.
Vaibhavi M.
Merck’s WINREVAIR Achieves Strong Phase 2 Results in CpcPH Linked To Heart Failure With Preserved Ejection Fraction , Advancing Toward Phase 3
Merck reports positive Phase 2 CADENCE results for WINREVAIR in CpcPH due to HFpEF, showing significant reduction in pulmonary vascular resistance.
Vaibhavi M.
